Work

Supplemental Material from A Biological Signature for Breast Ductal Carcinoma In Situ to Predict Radiotherapy Benefit and Assess Recurrence Risk

Year: 2023
Type: supplementary-materials
Abstract: A biologic signature for breast ductal carcinoma in situ to predict radiation therapy (RT) benefit and assess recurrence risk
Language: English
Subfield: Cancer Research
Open Access status: gold
OpenAlex ID: W4362405552
Cites:
Cited by:
Related to: 10